(Q43722893)

English

A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity

scientific article published on 17 June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity (English)

1 reference

Europe PubMed Central

26 November 2017

0 references

Jason Kindrachuk

1

object named as

Jason Kindrachuk

0 references

Scott A Halperin

9

object named as

Scott A Halperin

1 reference

Europe PubMed Central

26 November 2017

Robert E. W. Hancock

10

object named as

Robert E W Hancock

1 reference

Europe PubMed Central

26 November 2017

7

object named as

Volker Gerdts

1 reference

Europe PubMed Central

26 November 2017

8

object named as

Lorne A Babiuk

1 reference

Europe PubMed Central

26 November 2017

author name string

Jason Kindrachuk

1

1 reference

Europe PubMed Central

26 November 2017

Håvard Jenssen

2

1 reference

Europe PubMed Central

26 November 2017

Melissa Elliott

3

1 reference

Europe PubMed Central

26 November 2017

Rebecca Townsend

4

1 reference

Europe PubMed Central

26 November 2017

Anastasia Nijnik

5

1 reference

Europe PubMed Central

26 November 2017

Song F Lee

6

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

17 June 2009

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

27

1 reference

Europe PubMed Central

26 November 2017

34

1 reference

Europe PubMed Central

26 November 2017

4662-4671

1 reference

Europe PubMed Central

26 November 2017

Strategies to link innate and adaptive immunity when designing vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Vaccine adjuvants revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Immunomodulatory activities of small host defense peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Neutrophil-derived defensins as modulators of innate immune function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Monocyte-chemotactic activity of defensins from human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Mechanisms for induction of acquired host immunity by neutrophil peptide defensins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

An anti-infective peptide that selectively modulates the innate immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Therapeutic potential of Toll-like receptor 9 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Antibody repertoire development in fetal and neonatal piglets. IX. Three pathogen-associated molecular patterns act synergistically to allow germfree piglets to respond to type 2 thymus-independent and thymus-dependent antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Mechanisms of antimicrobial peptide action and resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Host defense peptides in wound healing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Separation and quantification of a novel two-component vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.094

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.05.094

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43722893&oldid=2102841188"